XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
US Stock MarketDetailed Quotes
SAGE Sage Therapeutics
- 7.140
- -0.040-0.56%
Close Feb 14 16:00 ET
- 7.160
- +0.020+0.28%
Post 20:01 ET
438.97MMarket Cap-1.08P/E (TTM)
7.225High7.110Low1.96MVolume7.200Open7.180Pre Close14.09MTurnover4.04%Turnover RatioLossP/E (Static)61.48MShares23.22052wk High0.94P/B347.18MFloat Cap4.62052wk Low--Dividend TTM48.62MShs Float195.970Historical High--Div YieldTTM1.60%Amplitude4.620Historical Low7.174Avg Price1Lot Size
Sage Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -33.03%504.42M | -33.03%504.42M | -35.03%569.15M | -35.49%646.79M | -36.52%717.01M | -40.81%753.18M | -40.81%753.18M | -37.14%876.05M | -33.76%1B | -30.50%1.13B |
| -Cash and cash equivalents | 14.13%81.02M | 14.13%81.02M | -33.01%99.63M | -17.72%99.9M | -16.41%172.65M | -56.37%70.99M | -56.37%70.99M | -25.58%148.71M | -41.21%121.42M | 15.61%206.56M |
| -Short-term investments | -37.94%423.4M | -37.94%423.4M | -35.45%469.53M | -37.94%546.89M | -41.02%544.36M | -38.53%682.19M | -38.53%682.19M | -39.07%727.34M | -32.59%881.2M | -36.19%923.03M |
| Receivables | -89.00%9.13M | -89.00%9.13M | -33.94%14.87M | -34.11%9.94M | -29.95%10.51M | 507.68%83.01M | 507.68%83.01M | 22.03%22.51M | -36.39%15.09M | -24.22%15M |
| -Related party accounts receivable | -89.00%9.13M | -89.00%9.13M | -33.94%14.87M | -34.11%9.94M | -29.95%10.51M | 507.68%83.01M | 507.68%83.01M | 22.03%22.51M | --15.09M | --15M |
| Restricted cash | --0 | --0 | --1.33M | --1.33M | --1.33M | --1.33M | --1.33M | ---- | ---- | ---- |
| Other current assets | -44.23%17.75M | -44.23%17.75M | -43.44%19.63M | -37.95%28.74M | -54.82%26.59M | -37.38%31.83M | -37.38%31.83M | --34.71M | --46.32M | --58.85M |
| Total current assets | -38.89%531.3M | -38.89%531.3M | -35.18%604.99M | -35.45%686.81M | -37.23%755.44M | -34.98%869.35M | -34.98%869.35M | -36.30%933.27M | -32.61%1.06B | -28.46%1.2B |
| Non current assets | ||||||||||
| Net PPE | 82.52%11.64M | 82.52%11.64M | 44.90%12.27M | -75.16%2.49M | -62.12%4.44M | -52.50%6.38M | -52.50%6.38M | -42.75%8.47M | -38.47%10.04M | -33.38%11.73M |
| -Gross PPE | -10.38%12.43M | -10.38%12.43M | 44.90%12.27M | -75.16%2.49M | -62.12%4.44M | -28.98%13.87M | -28.98%13.87M | -42.75%8.47M | -38.47%10.04M | -48.68%11.73M |
| -Accumulated depreciation | 89.53%-784K | 89.53%-784K | ---- | ---- | ---- | -22.85%-7.49M | -22.85%-7.49M | ---- | ---- | ---- |
| Related parties assets | -89.00%9.13M | -89.00%9.13M | -33.94%14.87M | -34.11%9.94M | -29.95%10.51M | 507.68%83.01M | 507.68%83.01M | 22.03%22.51M | --15.09M | --15M |
| Other non current assets | -34.67%4.28M | -34.67%4.28M | -34.70%5.18M | -5.12%7.8M | 39.68%7.72M | 8.43%6.55M | 8.43%6.55M | 28.28%7.93M | 33.11%8.22M | -5.73%5.52M |
| Total non current assets | 23.16%15.92M | 23.16%15.92M | 6.42%17.45M | -43.63%10.29M | -29.51%12.16M | -33.60%12.93M | -33.60%12.93M | -21.82%16.39M | -18.81%18.26M | -26.47%17.25M |
| Total assets | -37.98%547.22M | -37.98%547.22M | -34.46%622.43M | -35.59%697.11M | -37.12%767.6M | -34.96%882.28M | -34.96%882.28M | -36.10%949.66M | -32.42%1.08B | -28.44%1.22B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | 23.08%12.7M | 23.08%12.7M | -36.01%7.13M | -6.82%8.65M | -47.17%6.48M | -45.55%10.32M | -45.55%10.32M | 57.35%11.14M | 71.59%9.28M | 72.02%12.26M |
| -accounts payable | 23.08%12.7M | 23.08%12.7M | -36.01%7.13M | -6.82%8.65M | -47.17%6.48M | -45.55%10.32M | -45.55%10.32M | 57.35%11.14M | 71.59%9.28M | 72.02%12.26M |
| Current accrued expenses | -6.90%42.76M | -6.90%42.76M | -64.09%36.2M | -26.27%44.69M | -18.13%44.92M | 6.08%45.93M | 6.08%45.93M | 55.47%100.79M | -1.57%60.61M | -1.41%54.87M |
| Current debt and capital lease obligation | -74.48%1.32M | -74.48%1.32M | -98.81%83K | -81.73%1.41M | -56.98%3.31M | -32.42%5.17M | -32.42%5.17M | -8.37%6.97M | 2.14%7.73M | 2.14%7.68M |
| -Current capital lease obligation | -74.48%1.32M | -74.48%1.32M | -98.81%83K | -81.73%1.41M | -56.98%3.31M | -32.42%5.17M | -32.42%5.17M | -8.37%6.97M | 2.14%7.73M | 2.14%7.68M |
| Current liabilities | -13.45%71.62M | -13.45%71.62M | -54.58%60.41M | -28.68%69.04M | -27.03%61.8M | -16.64%82.75M | -16.64%82.75M | 33.42%133M | 8.48%96.81M | 8.99%84.69M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | --10.52M | --10.52M | --10.19M | ---- | ---- | --0 | --0 | --0 | -87.14%1M | -70.59%2.76M |
| -Long term capital lease obligation | --10.52M | --10.52M | --10.19M | ---- | ---- | --0 | --0 | --0 | -87.14%1M | -70.59%2.76M |
| Other non current liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 2.00%102K | 0.00%102K |
| Total non current liabilities | --10.52M | --10.52M | --10.19M | --0 | --0 | --0 | --0 | --0 | -86.01%1.11M | -69.84%2.87M |
| Total liabilities | -0.74%82.13M | -0.74%82.13M | -46.92%70.6M | -29.48%69.04M | -29.42%61.8M | -20.32%82.75M | -20.32%82.75M | 25.53%133M | 0.79%97.91M | 0.41%87.56M |
| Shareholders'equity | ||||||||||
| Share capital | 0.00%6K | 0.00%6K | 0.00%6K | 0.00%6K | 0.00%6K | 0.00%6K | 0.00%6K | 0.00%6K | 0.00%6K | 0.00%6K |
| -common stock | 0.00%6K | 0.00%6K | 0.00%6K | 0.00%6K | 0.00%6K | 0.00%6K | 0.00%6K | 0.00%6K | 0.00%6K | 0.00%6K |
| -Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | -15.59%-2.97B | -15.59%-2.97B | -13.31%-2.87B | -19.08%-2.78B | -23.13%-2.68B | -26.70%-2.57B | -26.70%-2.57B | -34.87%-2.54B | -33.93%-2.34B | -34.47%-2.17B |
| Paid-in capital | 1.93%3.44B | 1.93%3.44B | 2.03%3.43B | 2.54%3.41B | 2.16%3.39B | 2.40%3.37B | 2.40%3.37B | 2.48%3.36B | 1.95%3.33B | 2.03%3.31B |
| Less: Treasury stock | 0.00%400K | 0.00%400K | 0.00%400K | 0.00%400K | 0.00%400K | 0.00%400K | 0.00%400K | 0.00%400K | 0.00%400K | 0.00%400K |
| Gains losses not affecting retained earnings | 129.98%244K | 129.98%244K | 124.12%901K | 87.76%-691K | 84.53%-787K | 92.02%-814K | 92.02%-814K | 74.90%-3.74M | 59.31%-5.64M | 54.58%-5.09M |
| Total stockholders'equity | -41.83%465.09M | -41.83%465.09M | -32.43%551.84M | -36.20%628.06M | -37.71%705.8M | -36.17%799.53M | -36.17%799.53M | -40.83%816.66M | -34.56%984.38M | -29.99%1.13B |
| Total equity | -41.83%465.09M | -41.83%465.09M | -32.43%551.84M | -36.20%628.06M | -37.71%705.8M | -36.17%799.53M | -36.17%799.53M | -40.83%816.66M | -34.56%984.38M | -29.99%1.13B |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Trending Stocks
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call